External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024-12 · 44 (12) · 907-919
DOI: 10.1002/phar.4623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 15.11.2024. Verfasst von Mathieu Blouin und 9 weiteren Autor:innen. Beteiligte Einrichtung: STP2 Laboratory, Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Vancomycin, Bayes Theorem, Drug Monitoring, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Réseau Mère-Enfant de la Francophonie, CIHR, Brian White-Guay.
Abstract (Originalsprache)
Introduction
Guidelines for vancomycin therapeutic monitoring recommend using a Bayesian approach with a population pharmacokinetic model to estimate the 24 h area under the concentration‐time curve over first‐order equations. Thus, we performed an external evaluation of population pharmacokinetic models of vancomycin in neonates and compared Bayesian results with those observed in clinical practice via pharmacokinetic equations to improve therapeutic monitoring by proposing optimized initial dosing nomograms and assessing the feasibility of reduced blood sampling strategies using the most predictive models.
Methods
Models were identified from the literature and evaluated via an external neonatal population. A priori predictive performance was first assessed by prediction‐based diagnostics, then by simulation‐based diagnostics and a posteriori analyses only if deemed satisfactory; model‐informed vancomycin exposure was also compared with reference first‐order pharmacokinetic equations. The best‐performing models were ultimately subjected to Monte Carlo simulations to develop new initial dosing nomograms offering the highest probability of achieving therapeutic target.
Results
A total of 28 population pharmacokinetic models were evaluated in the external dataset, which includes 72 neonates and 380 vancomycin concentrations. Eleven models had an adequate predictive performance with bias ≤ ± 15% and imprecision 30%, while the Bayesian approach yielded over 75% agreement with reference exposure values in most cases. Nonetheless, Capparelli et al. and Mehrotra et al. models performed the best overall, showing the lowest imprecisions of 16.8% and 16.9%, respectively; both models recommended higher dosage regimens than the theoretical nomogram currently applied to favor therapeutic target attainment.
Discussion
We externally evaluated numerous neonatal population pharmacokinetic models of vancomycin and used the most predictive ones to advocate new initial dosing nomograms. Clinical implementation of the Bayesian approach could reduce the time needed to reach therapeutic target and limit the number of blood samples in newborns compared with traditional pharmacokinetic equations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- STP2 Laboratory, Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
- Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
- Department of Pharmacy, CHU Sainte-Justine, Montreal, Quebec, Canada.
- Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada.
- Department of Pharmacy, CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
- Research Center, CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
ORCID-Profile: Mathieu Blouin, Marie-Élaine Métras, Marie-Hélène Dubé, Marie-Christine Boulanger, Karine Cloutier, Mehdi El Hassani, Aysenur Yaliniz, Isabelle Viel-Thériault, Amélie Marsot
Förderung
- Réseau Mère-Enfant de la Francophonie
- CIHR
- Brian White-Guay
- Fonds de Recherche du Québec - Santé
- Canadian Institutes of Health Research
Zitieren
APA
Blouin, M., Métras, M. É., Gaudreault, C., Dubé, M. H., Boulanger, M. C., Cloutier, K., El Hassani, M., Yaliniz, A., Viel-Thériault, I., & Marsot, A. (2024). External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 44(12), 907-919. https://doi.org/10.1002/phar.4623
Vancouver
Blouin M, Métras MÉ, Gaudreault C, Dubé MH, Boulanger MC, Cloutier K, et al. External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024;44(12):907-919. doi:10.1002/phar.4623
BibTeX
@article{Blouin2024,
author = {Blouin, Mathieu and Métras, Marie-Élaine and Gaudreault, Camille and Dubé, Marie-Hélène and Boulanger, Marie-Christine and Cloutier, Karine and El Hassani, Mehdi and Yaliniz, Aysenur and Viel-Thériault, Isabelle and Marsot, Amélie},
title = {External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2024},
volume = {44},
number = {12},
pages = {907--919},
doi = {10.1002/phar.4623}
}
EUVIMED